Skip to main content
Clinical Trials/NCT06240533
NCT06240533
Not yet recruiting
Not Applicable

Implementation of a Patient Centered Coordinated Care Pathway for Low Back Pain (P3C-LBP) in Swedish Primary Care

Linkoeping University1 site in 1 country300,000 target enrollmentFebruary 1, 2024
ConditionsLow Back Pain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Low Back Pain
Sponsor
Linkoeping University
Enrollment
300000
Locations
1
Primary Endpoint
Cost of health care per month for LBP
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

The goal of this observational study is to evaluate the implementation of a patient centered coordination care (P3C) pathway for the management of patients with low back pain (LBP) in primary care, in Östergötland health care region, Sweden.

The main questions the study aims to answer are:

  • Do health care quality indicators improve over time after repeated implementation interventions of a P3C pathway for patients with LBP.
  • What are the health care practitioner perspectives regarding barriers and facilitators determining implementation success of a P3C pathway for patients with LBP.

Detailed Description

BACKGROUND Since 2019, the Swedish government together with regional health care organisations have actioned the national development of patient centered coordinated care (P3C) pathways. P3C pathways are defined as health care processes guided by and organized effectively around the needs and preferences of the patient. The aim of this observational study is to evaluate the implementation of a patient centered coordination care (P3C) pathway for the management of patients with low back pain (LBP) in primary care, Östergötland health care region, Sweden. The P3C pathway covers primary care processes until the patient can self-manage or transitions to established chronic pain or other specialist care pathways. A national work group was formed consisting of representatives from all regional health care organisations in Sweden and included all relevant health care professions, academia, and patient organisations. METHODS: A mixed methods iterative design and consensus approach was applied in the development of the P3C pathway. The study will be performed in 3 phases: Phase 1 - Historical baseline: Retrospective register based study of health care quality indicators covering historical time series data before dissemination of the P3C pathway for LBP (January 2013-June 2023). Phase 2 - Dissemination by publication: Prospective register based study of health care quality indicators for phase 1 (January 2013-June 2023) compared to phase 2 (June 2023- February 2024) after dissemination by publication of the P3C pathway for LBP. Phase 3 - Single-faceted implementation: Prospective register based study of health care quality indicators for phases 1+2 (January 2013-February 2024) compared to phase 3 (March 2024-February 2026) after single-faceted implementation (health care practitioner workshop) of the P3C pathway for LBP. Health care practitioner confidence in managing LBP and perspectives regarding barriers and facilitators determining implementation P3C pathway success will also be investigated via questionnaires directly after and 1 year prospectively after the implementation intervention. The qualitative interviews will be performed 3- 6 months post implementation. Phase 4 - Multi-faceted implementation (repeated health care practitioner workshops and follow-up): Prospective register based study of health care quality indicators for phases 1+2+3 (January 2013-February 2026) compared to phase 4 (March 2026-December 2027) after multi-faceted implementation of the P3C pathway for LBP.

Registry
clinicaltrials.gov
Start Date
February 1, 2024
End Date
December 31, 2027
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Linkoeping University
Responsible Party
Principal Investigator
Principal Investigator

Allan Abbott

Professor

Linkoeping University

Eligibility Criteria

Inclusion Criteria

  • All patients with the low back diagnosis (M.54.5, M54.4, M54.3, M54.9) with a visit in primary care and patients with diagnosis M43.0,M43.1, M43.9,M47(all but not M47.0),M48.0, M48.0K, M48.8,M48.8K, M48.9, M51.0, M51.0K, M51.1,M51.1K, M51.2, M51.3, M51.4, M51.8, M51.9, M53.2, M53.3, M53.8,M53.9 referred from primary to specialist care for LBP.
  • General practitioners and primary health care nurses participating in P3C implementation workshops

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Cost of health care per month for LBP

Time Frame: Monthly January 2013 to December 2027

Registry data from the Östergötland health care region database for diagnosis codes (ICD10: M54.5, M54.4, M54.3, M54.9)

Practitioner Confidence Scale

Time Frame: February 2024 and February 2025

Healthcare practitioner rated´confidence in managing low back pain before and after a single-faceted implementation. The Practitioner Confidence Scale contains four items reported on a 5-point Likert scale, where a total score of 4 represents greatest self-confidence and 20 represents lowest self-confidence for managing patients with LBP.

Patient sickness benefit days per month for LBP

Time Frame: Monthly January 2013 to December 2027

Registry data from The Swedish Social Insurance Agency for diagnosis codes (ICD10: M54.5, M54.4, M54.3, M54.9)

Secondary Outcomes

  • Determinants of Implementation Behaviour Questionnaire(February 2024 and February 2025)
  • Prescription of NSAIDS for LBP(Monthly January 2013 to December 2027)
  • Prescriptions of antidepressants for LBP(Monthly January 2013 to December 2027)
  • Qualitative focus group interview(September 2024 to May 2025)
  • Referrals to specialist pain rehabilitation clinics(Monthly January 2013 to December 2027)
  • Prescriptions of paracetamol for LBP(Monthly January 2013 to December 2027)
  • Referrals to specialist orthopedic clinics(Monthly January 2013 to December 2027)
  • New visits in primary care to physicians and physiotherapists for LBP(Monthly January 2013 to December 2027)
  • Use of medical imaging for LBP(Monthly January 2013 to December 2027)
  • Prescriptions of opioids for LBP(Monthly January 2013 to December 2027)
  • Prescriptions of gabapentinoids for LBP(Monthly January 2013 to December 2027)
  • Prescriptions of muscle relaxants for LBP(Monthly January 2013 to December 2027)

Study Sites (1)

Loading locations...

Similar Trials